The Latest
The Proposed Musk Efficiency Commission Could Save Trillions
Trump saying that trillions of dollars can be saved from a government efficiency commission headed by Musk isn't an exaggeration.
Price Controls Are Always a Bad Idea
Prices controls have always disrupted the marketplace and created shortages or excesses.
The Future of the Universal Service Fund
To save taxpayer dollars, Congress should look at revamping the USF program instead of trying to expanding its contribution base.
The Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the...

340B Drug Pricing Program Briefing
Despite the intentions of the program to help patients, Congress did not provide a clear definition of who should benefit from 340B.
Citizens Against Government Waste Names Rep. Pramila Jayapal September 2024 Porker of the Month
Rep. Jayapal is trying to force taxpayers to pay taxes on unrealized gains on investments.
Protecting Intellectual Property in an AI World
Intellectual property rights should be protected when artificial intelligence is used in creative works.
Council for Citizens Against Government Waste Releases 2023 Congressional Ratings
CCAGW's Congressional Ratings identifies members who helped protect taxpayers, as well as those who voted against their interests.
CCAGW Submits Comments to House Energy and Commerce Hearing on Oversight Hearing of FDA Human Foods and Tobacco Programs
Millions of Americans use tobacco harm reduction products each year to quit smoking.
Reforming 340B vital for affordable medication for low-income patients
Unfortunately, today, the 340B program is failing those it was meant to serve.
The Biden-Harris rent control ruse would worsen the housing shortage, raise costs
Proposal to cap rent increases at 5 percent would reduce the stock of available homes.
USPTO-FDA Study Debunks Critics and Demonstrates the Importance of Protecting IP
USPTO-FDA study reinforces the need to protect pharmaceutical intellectual property rights for the future of new drug development.